This is the authors' abstract. We don't add key points for this paper.
This study demonstrates clinical utility for the use of baseline IRG expression levels as a predictive biomarker for non-response to RTX in RA.
Answers are grounded in this paper and cite their sources.
No takes yet. Share an insight, caveat, or question.
Raterman et al. (2012) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: